1.0Times South Africahttps://timessouthafrica.comTSAhttps://timessouthafrica.com/author/tsa/Zenas BioPharma renforce sa direction avec la nomination de Jennifer Fox en tant que Chief Business Officer et Chief Financial Officer et de Tanya Fischer, M.D., PhD., en tant que Head of R&D et Chief Medical Officer - Times South Africarich600338<blockquote class="wp-embedded-content" data-secret="GlLgRjpYI1"><a href="https://timessouthafrica.com/zenas-biopharma-renforce-sa-direction-avec-la-nomination-de-jennifer-fox-en-tant-que-chief-business-officer-et-chief-financial-officer-et-de-tanya-fischer-m-d-phd-en-tant-que-head-of-rd-et-c/">Zenas BioPharma renforce sa direction avec la nomination de Jennifer Fox en tant que Chief Business Officer et Chief Financial Officer et de Tanya Fischer, M.D., PhD., en tant que Head of R&D et Chief Medical Officer</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://timessouthafrica.com/zenas-biopharma-renforce-sa-direction-avec-la-nomination-de-jennifer-fox-en-tant-que-chief-business-officer-et-chief-financial-officer-et-de-tanya-fischer-m-d-phd-en-tant-que-head-of-rd-et-c/embed/#?secret=GlLgRjpYI1" width="600" height="338" title="“Zenas BioPharma renforce sa direction avec la nomination de Jennifer Fox en tant que Chief Business Officer et Chief Financial Officer et de Tanya Fischer, M.D., PhD., en tant que Head of R&D et Chief Medical Officer” — Times South Africa" data-secret="GlLgRjpYI1" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
</script>
Le renforcement du leadership stratégique et opérationnel permet à Zenas de se développer et les essais cliniques en phase avancée sur l’obéxélimab progressent, pour de multiples indications potentielles dans l’I&I WALTHAM, Massachusetts, 04 déc. 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, un laboratoire biopharmaceutique d’envergure mondiale déterminé à devenir un leader dans le développement et la commercialisation […]https://ci5.googleusercontent.com/proxy/c9ia8ApSoli9tg-u5tTiiv03R_ZGr9eVEYz6cr6v_ThxOBwsBq46tTVp6r3hfSQ1RKOfqdRdTEjMEku3HPWxMk9rn3DCWrDQgLbjyCZ-ba9fn-q6ThBt2SPEIi0o3pgin1KmOfiPEHWNyPSKdwTGdWC1gd6r3NrwEwZkPGLThbcpURuOHsV7wvVbgWPl2yhxHYnLFg=s0-d-e1-ft#https://ml.globenewswire.com/media/MWZhZDMyNGUtOTE0OC00NzBhLTljODAtYTAwODE2NGM2ZWFlLTEyMTkzNDg=/tiny/Zenas-BioPharma-USA-LLC.png